Month: June 2016
-
Antibody Treatment Shown to Prevent Migraine
9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology. Migraine is a neurological syndrome…
-
FDA Clears Insomnia Relief Device
8 June 2016. A device that helps people with insomnia get to sleep without taking drugs received clearance for marketing in the U.S. from the Food and Drug Administration. The device, developed by the company Cerêve in Pittsburgh, Pennsylvania, will require a prescription once it’s on the market in the U.S., expected in the second…
-
Kauffman Index Shows Higher Start-Up Growth in 2016
8 June 2016. An index of high-growth start-up companies shows the rate of entrepreneurial expansion in the U.S. accelerated for the third year in a row, with greatest concentration of growing enterprises found in the Washington, D.C. region. The Ewing Marion Kauffman Foundation in Kansas City, Missouri yesterday issued its annual Index of Growth Entrepreneurship…
-
Precision Medicine Shown to Boost Cancer Outcomes
7 June 2016. An analysis of results from early-stage clinical trials shows trials using treatments for cancer aimed at specific molecular targets had higher response rates and longer survival times than studies not using these targets. The team from University of California in San Diego, led by postdoctoral researcher Maria Schwaederlé, published its findings in…
-
Blood Test Guides Depression Drug Decisions
7 June 2016. A blood test for two key biomarkers can identify drugs for depression that match an individual’s condition with the disease, thus improving chances of success. A team from the lab of psychological medicine professor Carmine Pariante at Kings College London published its findings yesterday in the International Journal of Neuropsychopharmacology. Pariante’s team,…
-
Engineered T-Cells Get Leukemia Response
(6 June 2016) An early-stage clinical trial testing genetically engineered T-cells from the immune system, shows the treatments are effective against a form of leukemia when combined with chemotherapy drugs. Results of the trial were reported by study leader Jae Hong Park of Memorial Sloan Kettering Cancer Center on 4 June at a meeting of…
-
Biomaterials Solutions Studied for Chronic Wounds
3 June 2016. A team of materials and medical scientists is investigating a new process of applying protein-based biomaterials to the healing of chronic wounds. The research led by materials scientists Millicent Sullivan and Kristi Kiick at University of Delaware in Newark is funded by a 4 year, $1.4 million grant from National Institute of…
-
Trial Shows Feasibility of Wearable Dialysis Device
3 June 2016. An early clinical trial shows a wearable device can provide the same dialysis functions as conventional stationary equipment for people with kidney failure. A team from University of Washington in Seattle and Cedar-Sinai Medical Center in Los Angeles reported results of the trial in yesterday’s issue of the journal JCI Insight. The…
-
Why Design Alone Isn’t Enough for a Successful Website
– Sponsored Content – (3 June 2016) When working on your website, try not to get too caught up in what it will look like. Sure, the overall design and attractiveness of your site is really important, but in order for it to be a true asset to your brand and business, you need to…
-
Industries Where SAP Skills Will Benefit You
(3 June 2016) If you are looking to go into business in a specific industry, it pays to know the kind of technology that is used within your sector even if the role you plan to play in your business is not a technical one. If you are planning to consult as an IT specialist…